Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 277

Results For "MS"

5610 News Found

Orchid Pharma and Cipla collaborate to launch antibiotic Cefepime-Enmetazobactam in India
News | June 29, 2024

Orchid Pharma and Cipla collaborate to launch antibiotic Cefepime-Enmetazobactam in India

The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR


HCG acquires 51% stake in Mahatma Gandhi Cancer Hospital and Research Institute, Vizag
News | June 29, 2024

HCG acquires 51% stake in Mahatma Gandhi Cancer Hospital and Research Institute, Vizag

Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza


Sanofi Consumer Healthcare India appoints Himanshu Bakshi as MD
Appointment | June 27, 2024

Sanofi Consumer Healthcare India appoints Himanshu Bakshi as MD

Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles


Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India
Healthcare | June 27, 2024

Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India

Glenmark released Picture Post Cards on World Vitiligo Day


Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital
News | June 27, 2024

Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital

Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation


Shilpa Medicare Bio Analytical unit gets
Drug Approval | June 27, 2024

Shilpa Medicare Bio Analytical unit gets "No Action Indicated" classification from USFDA

This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies


CCRAS hosts national consultative meet on traditional medicine
Policy | June 26, 2024

CCRAS hosts national consultative meet on traditional medicine

Signs MoUs with Shri Krishna Ayush University and Dabur India


USDA approves Merck Animal Health’s NOBIVAC NXT canine flu H3N2
Drug Approval | June 26, 2024

USDA approves Merck Animal Health’s NOBIVAC NXT canine flu H3N2

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease


Ascentage Pharma closes US$ 75 million equity investment by Takeda
News | June 24, 2024

Ascentage Pharma closes US$ 75 million equity investment by Takeda

Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO